Grim Outlook For UK Biotech Industry

According to PharmExec.com, the UK biotech industry could see a massive change for the worse if there isn't a turn around in profits. The article states, that one-third of publicly owned UK biotechs have less than six months’ money left in the bank, and just 0.2 percent of the London Stock Exchange is now made up of biotech companies. This could have disasterious rippling effects on the global biotech industry. After reading the full article here, what are your thoughts on the UK biotech industry?

Share this article with your social network, just click below to share now!

Share |